埃泽蒂米布有效地降低了血植物类固醇在患者的细胞固醇高血
G Salen1, K von Bergmann, D Lütjohann
1UMDNJ-New Jersey Medical School, Newark, NJ 07103, USA. SalenGe@UMDNJ.edu
Circulation
|February 11, 2004
概括
埃泽蒂米布通过抑制肠道吸收,显著降低了高植物类固醇水平在菌体病患者. 这种治疗有效地降低了固醇和固醇,为这种遗传性疾病提供了潜在的治疗策略.
科学领域:
- 心脏病学 心脏病学
- 遗传学 是一个遗传学.
- 药理学 药理学 是一个学科.
背景情况:
- 胆固醇血症是一种罕见的遗传性疾病,其特征是饮食中的固醇吸收增加和分泌受损.
- 在ABCG5或ABCG8基因的突变导致血和组织中的植物类固醇水平升高,如固醇和固醇.
- 血胆固醇症患者的高胆固醇水平有助于早期动脉样硬化的发展.
研究的目的:
- 研究一种胆固醇吸收抑制剂ezetimibe的有效性,用于降低患者的植物醇水平.
- 评估ezetimibe治疗在这个患者群体中的安全性和耐受性.
主要方法:
- 进行了一项多中心,双盲,随机,安慰剂控制的研究.
- 在3周的安慰剂试验期后,37名患有静质血症的患者被随机分配给接受ezetimibe (10 mg/天) 或安慰剂8周.
- 血中西托斯特醇,坎普斯特醇和其他类固醇的水平每两周测量一次.
主要成果:
- 与安慰剂组的4%的增加相比,以泽提治疗导致醇水平显著下降21% (P<0.001).
- 坎普斯特醇水平也显示出以泽提米布的显著渐进性下降,下降了24% (P<0.001) 与安慰剂的3%的增加相比.
- 无论是否同时使用树脂或他类药物治疗,都观察到植物醇的减少. 埃泽蒂米布耐受性很好,没有严重的不良事件.
结论:
- 埃泽提米布有效地降低了血植物醇度,在患者中 sitosterolemia.
- 这些发现支持ezetimibe抑制肠道吸收植物固醇和胆固醇的机制.
- 埃泽提米布代表了一种安全有效的治疗选择,用于管理在细胞固醇中高植物固醇血症.
相关概念视频
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
01:10Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
01:28Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...